You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 10, October 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Radiation Therapy
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Selecting Patients for Planned Neck Dissection After Chemoradiotherapy in Regionally Advanced Head and Neck Cancer

Jai Prakash Agarwal, MD; Indranil Mallick, MD, DNB; Sarbani Ghosh-Laskar, MD, DNB; Tejpal Gupta, MD, DNB; Ashwini Budrukkar, MD, DNB; Vedang Murthy, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We thank Lau et al1 for presenting their experience with observation after a clinical complete response (CR) to radical chemoradiotherapy in regionally advanced head and neck cancer. The issue of neck dissection after a clinical CR has been a matter of contention. Several reports have presented data for and against planned neck dissection.

The need of the hour is to identify those patients who have the highest risk of subclinical residual disease despite a clinicoradiologic CR. Nodal diameter would be one of the most important predictive factors.2 It would also be a surrogate marker for tissue hypoxia, predicting a relative resistance to radiation therapy. Signs of extracapsular extension (ECE) on clinical or radiologic examination would be another important factor that may benefit from the removal of neck . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Absence of Planned Neck Dissection for the N2-N3 Neck After Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Harold Lau, Tien Phan, Jack MacKinnon, and T. Wayne Matthews
Arch Otolaryngol Head Neck Surg. 2008;134(3):257-261.
ABSTRACT | FULL TEXT  

RELATED LETTER

Selecting Patients for Planned Neck Dissection After Chemoradiotherapy in Regionally Advanced Head and Neck Cancer—Reply
Harold Lau
Arch Otolaryngol Head Neck Surg. 2008;134(10):1122.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.